- Accession Number:
- Form Type:
- Zero Holdings:
- Publication Time:
- 2014-12-19 10:23:50
- Reporting Period:
- Filing Date:
- Accepted Time:
- 2014-12-19 10:23:50
- SEC Url:
- Form 4 Filing
|Cik||Name||Symbol||Sector (SIC)||IRS No|
|890465||Nps Pharmaceuticals Inc||NPSP||Biological Products, (No Disgnostic Substances) (2836)||870439579|
|Cik||Name||Reported Address||Insider Title||Director||Officer||Large Shareholder||Other|
|1192128||M Luke Beshar||550 Hills Drive |
Bedminster NJ 07921
|Evp & Cfo||No||Yes||No||No|
|Sec. Name||Acquisiton - Disposition||Date||Amount||Price||Remaning Holdings||Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Sec. Name||Sec. Type||Acquisiton - Disposition||Date||Amount||Price||Amount - 2||Price - 2|
|Common Stock||Employee Stock Options (right to buy)||Disposition||2014-12-17||11,500||$0.00||11,500||$3.34|
|Common Stock||Employee Stock Options (right to buy)||Disposition||2014-12-17||8,906||$0.00||8,906||$8.21|
|Common Stock||Employee Stock Options (right to buy)||Disposition||2014-12-17||31,852||$0.00||31,852||$8.23|
|Remaning Holdings||Exercise Date||Expiration Date||Equity Swap Involved||Transaction Form Type||Transaction Code||Nature of Ownership|
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- On February 19, 2010, the Reporting Person received a grant of 40,000 stock options under NPS Pharmaceuticals, Inc.'s (the "Issuer") 2005 Omnibus Incentive Plan, which are subject to both performance conditions and time-based vesting. As of the date of this filing, the performance criteria and the time-based criteria for 31,812 of these options has been satisfied. These options vested and became exercisable based on the following vesting schedule: 25% on each of the first four anniversaries of the date of grant.
- On February 7, 2012, the Reporting Person received a grant of 47,500 stock options under the Issuer's 2005 Omnibus Incentive Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter.
- On February 13, 2013, the Reporting Person received a grant of 84,941 stock options under the Issuer's 2005 Omnibus Incentive Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter.